Precision Biosciences Inc SEC filings DTIL
Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 6, 2026 | — |
| FWP | Free writing prospectus | Nov 5, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| S-3 | Shelf registration | Dec 30, 2025 | — |
| S-8 | Employee stock plan registration | Dec 30, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 10, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| FWP | Free writing prospectus | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| S-3 | Shelf registration | Jun 9, 2023 | — |
| S-8 | Employee stock plan registration | Aug 26, 2022 | — |
| 424B4 | Prospectus | Jun 22, 2022 | — |
| S-8 | Employee stock plan registration | Sep 7, 2021 | — |
| S-3 | Shelf registration | Jun 1, 2020 | — |
| S-8 | Employee stock plan registration | Apr 1, 2019 | — |
| 424B4 | Prospectus | Mar 28, 2019 | — |
| S-1/A | Amended registration statement | Mar 18, 2019 | — |
| S-1/A | Amended registration statement | Mar 13, 2019 | — |
| S-1 | Registration statement | Mar 1, 2019 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DTIL (Nasdaq)
- Fiscal year ends
- May 21
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357874
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.